ALCAM and colorectal carcinoma: In the comparison of 931 patients with left-sided CRC and 538 patients with right-sided CRC (Figure 5), the results from four studies demonstrated that no significant correlation was observed between CD166 expression and tumor location under the random-effects model (OR = 0.59, 95% CI = 0.28-1.21, P = 0.15).